PIA
REGN icon

Piedmont Investment Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History

Piedmont Investment Advisors’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-12,076
Closed -$5.9M – 544
2020
Q1 		$5.9M Buy
12,076
+595
+5% +$245K 0.23% 101
2019
Q4 		$4.31M Buy
11,481
+8,992
+361% +$3.03M 0.15% 153
2019
Q3 		$690K Buy
2,489
+85
+4% +$25.2K 0.03% 414
2019
Q2 		$752K Sell
2,404
-15,205
-86% -$5.06M 0.03% 397
2019
Q1 		$7.23M Buy
17,609
+7,290
+71% +$3M 0.29% 83
2018
Q4 		$3.85M Buy
10,319
+414
+4% +$152K 0.18% 123
2018
Q3 		$4M Buy
9,905
+3,143
+46% +$1.2M 0.17% 131
2018
Q2 		$2.33M Sell
6,762
-8,063
-54% -$2.52M 0.11% 191
2018
Q1 		$5.11M Sell
14,825
-5,113
-26% -$1.78M 0.14% 183
2017
Q4 		$7.5M Buy
19,938
+127
+0.6% +$51.4K 0.15% 175
2017
Q3 		$8.86M Buy
19,811
+3,076
+18% +$1.46M 0.19% 142
2017
Q2 		$8.22M Buy
16,735
+276
+2% +$121K 0.18% 147
2017
Q1 		$6.38M Sell
16,459
-1,057
-6% -$392K 0.13% 192
2016
Q4 		$6.43M Buy
17,516
+347
+2% +$132K 0.13% 177
2016
Q3 		$6.9M Sell
17,169
-451
-3% -$181K 0.15% 161
2016
Q2 		$6.15M Buy
17,620
+28
+0.2% +$10.8K 0.13% 176
2016
Q1 		$6.34M Buy
17,592
+270
+2% +$111K 0.13% 164
2015
Q4 		$9.4M Buy
17,322
+152
+0.9% +$82.4K 0.2% 128
2015
Q3 		$7.99M Buy
17,170
+139
+0.8% +$74.6K 0.18% 140
2015
Q2 		$8.69M Buy
+17,031
New +$8.31M 0.18% 140

Other funds holding REGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Polen Capital Management
Polen Capital Management Boca Raton, Florida $14.5B AUM 5.7% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Piedmont Investment Advisors's REGN Position: Q2 2020 in Review

Piedmont Investment Advisors sold out of Regeneron Pharmaceuticals (REGN) in Q2 2020, closing a stake of 12,076 shares — an estimated $5.9M sold.

Piedmont Investment Advisors first reported a position in REGN in Q2 2015 and held it in 20 quarters. The position peaked at $9.4M in Q4 2015. 933 funds tracked by Wall St. Rank hold REGN as of Q2 2020.

  • Piedmont Investment Advisors reported no remaining Regeneron Pharmaceuticals position as of Q2 2020 after selling out during the quarter.
  • Piedmont Investment Advisors sold 12,076 Regeneron Pharmaceuticals shares in Q2 2020, an estimated $5.9M.
  • Piedmont Investment Advisors first reported a position in Regeneron Pharmaceuticals in Q2 2015 and held it in 20 quarters.
  • Piedmont Investment Advisors's Regeneron Pharmaceuticals position peaked at $9.4M in Q4 2015.
  • 933 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2020.

Based on Piedmont Investment Advisors's 13F filing for Q2 2020.